Interpreting a DCF for a Stable Industrial Company

i

I would first translate the percentage into an actual value to understand how much of the DCF valuation depends on long-term assumptions.

So approximately €600m of the €800m valuation comes from the Terminal Value.

Next, I would calculate how much value comes from the explicit forecast period.

This means that only about €200m of value comes from the explicit forecast period, while the majority comes from the assumed value of the business beyond that period.

This is not automatically a red flag. In many DCFs, the Terminal Value can represent a large share of total value because the explicit forecast period only covers a limited number of years, while the Terminal Value captures all cash flows after that period.

However, it does mean that the valuation is very sensitive to long-term assumptions. The 2.0% terminal growth rate, the 9.0% WACC, and the assumed steady-state profitability need to be carefully validated.

For a mature industrial company, a high Terminal Value contribution can be reasonable if the company has stable cash flows, sustainable margins, and moderate long-term growth. But if the long-term assumptions are too optimistic, the €800m valuation could be overstated.

Lower EBITDA margins would reduce profitability and therefore reduce free cash flow.

In a DCF, the impact would come through several steps:

Lower margin → lower EBITDA → lower operating cash flow → lower free cash flow → lower valuation

This matters because the valuation is based on future free cash flows, not just revenue. If the company generates less EBITDA from the same revenue base, there is less cash available after taxes, CapEx, and working capital.

The impact would affect both parts of the DCF.

In the explicit forecast period, lower margins would reduce annual projected cash flows. In the Terminal Value, lower margins would reduce the steady-state cash flow level, which is especially important here because the Terminal Value accounts for 75% of total value.

So even a small margin reduction could have a meaningful impact. The effect can be amplified because lower margins reduce not only near-term cash flows, but also the long-term cash flow base used to calculate Terminal Value.

If WACC increases, the DCF valuation decreases.

There are two reasons. First, all projected future cash flows are discounted at a higher rate. This reduces their present value. Second, the Terminal Value decreases because the spread between WACC and terminal growth becomes larger.

Using the simplified Gordon Growth formula:

Terminal Value formula: Final year free cash flow × (1 + g) / (WACC - g)

Holding everything else constant, the Terminal Value would fall because the denominator increases from 7.0% to 8.0%.

A quick way to estimate the directional impact on the Terminal Value is to compare the old spread with the new spread.

This means the undiscounted Terminal Value would be approximately 12.5% lower before considering the additional effect of higher discounting.

Since 75% of the total valuation comes from the Terminal Value, this WACC increase would likely have a material negative impact on the €800m Enterprise Value.

So the key takeaway is: a 1 percentage point increase in WACC can have a significant effect, especially when the DCF is heavily driven by Terminal Value.

I would start with the implied EV/EBITDA multiple. This allows me to compare the DCF output with market benchmarks such as trading comparables and precedent transactions.

The first sanity check is whether a 10.0x EBITDA multiple is reasonable for a stable industrial company with moderate growth. To assess that, I would compare it to publicly listed comparable companies and precedent transactions in the same or similar industrial subsector.

If comparable companies trade around a similar multiple, the DCF output may be reasonable. If peers trade significantly below 10.0x, for example at 7.0x or 8.0x, I would question whether the DCF assumptions are too optimistic. If peers trade significantly above 10.0x, the valuation might be conservative, depending on the company’s quality.

I would also sanity-check the key DCF assumptions:

• Is the 2.0% terminal growth rate realistic for a mature industrial company?
• Is the 9.0% WACC appropriate for the company’s risk profile?
• Are the margin and growth assumptions consistent with historical performance?
• Are CapEx and working capital assumptions realistic?
• Does the company actually convert EBITDA into free cash flow?

Finally, I would cross-check the DCF against other valuation methods, especially trading comparables and precedent transactions.

A DCF should not be used in isolation. If the DCF implies a multiple that is far away from market benchmarks, I would revisit the assumptions before relying on the valuation.

I would first compare the seller’s asking price to our DCF valuation.

Next, I would calculate the percentage premium.

I would also calculate the implied EV/EBITDA multiple at the seller’s price.

Whether this premium is acceptable depends on the buyer’s view of the asset. There is no universal rule that a 12.5% premium is “normal” or “too high.” It depends on factors such as competitive tension, strategic value, synergy potential, growth outlook, and confidence in the DCF assumptions.

The premium could be justified if the buyer believes that:

• the DCF assumptions are too conservative,
• the company can outperform the base case,
• there are meaningful synergies,
• the buyer has a clear value creation plan,
• or comparable transactions support a higher multiple.

However, given that the valuation is already highly sensitive to Terminal Value assumptions, paying above the DCF value increases the risk. At €900m, the buyer needs stronger conviction that the company can deliver upside beyond the base case.

My view would be: €900m is not automatically unreasonable, but it requires a clear justification. Without synergies, stronger growth, or a credible upside case, the price looks aggressive relative to the €800m DCF valuation.

I would want to validate the assumptions that have the greatest impact on the valuation.

1. The first area is free cash flow quality. EBITDA is €80m, but the DCF depends on free cash flow. I would review CapEx, working capital requirements, cash taxes, and any recurring one-off costs to understand how much EBITDA actually converts into cash.
2. The second area is margin sustainability. Since the company operates in a mature industrial market, I would want to understand whether margins are stable because of strong competitive advantages or whether they are at risk from pricing pressure, input cost inflation, or customer concentration.
3. The third area is terminal assumptions. Since 75% of the valuation comes from Terminal Value, I would carefully validate the 2.0% terminal growth rate, steady-state margins, capital intensity, and long-term reinvestment needs.

I would also validate the WACC. The 9.0% discount rate should reflect the company’s risk profile, cyclicality, capital structure, and market conditions.

Finally, I would compare the valuation to market benchmarks, including comparable companies and precedent transactions, to understand whether the implied 10.0x EV/EBITDA multiple is realistic.

So the diligence should focus on the areas where a small assumption change could materially change the valuation.

I would not recommend pursuing the acquisition at €900m without further support for the premium.

The DCF indicates an Enterprise Value of €800m, which implies a 10.0x EV/EBITDA multiple. The seller’s asking price of €900m implies 11.25x EBITDA and a 12.5% premium to the DCF valuation.

That premium could be justified, but only if there is a credible reason to believe that the company is worth more to the buyer than reflected in the base-case DCF. For example, the buyer would need confidence in stronger growth, margin upside, synergies, or other value creation levers.

The main concern is that the DCF is already heavily driven by Terminal Value. Since 75% of the total value comes from long-term assumptions, the valuation is sensitive to WACC, terminal growth, and steady-state profitability. Paying above that valuation increases the risk of overpaying.

So my recommendation would be: continue evaluating the acquisition, but do not accept the €900m price based on the current information.

I would either try to negotiate closer to the €800m valuation or require additional evidence that supports the higher price. That evidence could include stronger market multiples, confirmed synergies, more resilient free cash flow, or a credible upside case.

In short: the acquisition may still be attractive, but at €900m the buyer needs a stronger investment case than the current DCF alone provides.